Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo

By                

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 833-841

Spandidos Publications

Access to resources Recommend Favorite

Growth inhibitory effect of p21 and p53 containing adenoviruses on transitional cell carcinoma cell lines in vitro and in vivo

By McGarvey T.W.   Meng R.D.   Johnson O.   El-Deiry W.   Malkowicz S.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 4, 2001-07 ,pp. : 155-162

Elsevier

Access to resources Recommend Favorite

Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery

By  

Current Cancer Therapy Reviews, Vol. 11, Iss. 3, 2015-09 ,pp. : 136-153

Bentham Science Publishers

Access to resources Recommend Favorite

Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials

By Ibrahim George  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 623-627

Springer Publishing Company

Access to resources Recommend Favorite

Clinical study of recombinant adenovirus- p 53 (Ad p 53) combined with hyperthermia in advanced cancer (a report of 15 cases)

By Zhang S.   Xu G.   Liu C.   Xiao S.   Sun Y.   Su X.   Cai Y.   Li D.   Xu B.  

International Journal of Hyperthermia, Vol. 21, Iss. 7, 2005-11 ,pp. : 631-636

Informa Healthcare

Access to resources Recommend Favorite